VIP in Liposomes Injected Into the Eye Treats Experimental Autoimmune Uveitis

Intravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treating inflammatory eye disease.

RPEP-014602009RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Intravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treating inflammatory eye disease.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding Intravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treatin
Evidence Grade:
emerging evidence.
Study Age:
Published in 2009.
Original Title:
Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Published In:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 25(1), 9-21 (2009)
Database ID:
RPEP-01460

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

VIP in Liposomes Injected Into the Eye Treats Experimental Autoimmune Uveitis

What was found?

Intravitreal injection of VIP-loaded liposomes protected against autoimmune uveitis in rats, demonstrating sustained neuropeptide delivery for treating inflammatory eye disease.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01460·https://rethinkpeptides.com/research/RPEP-01460

APA

Camelo, Serge; Lajavardi, Laure; Bochot, Amélie; Goldenberg, Brigitte; Naud, Marie-Christine; Brunel, Nadège; Lescure, Bernadette; Klein, Christophe; Fattal, Elias; Behar-Cohen, Francine; de Kozak, Yvonne. (2009). Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 25(1), 9-21. https://doi.org/10.1089/jop.2008.0074

MLA

Camelo, Serge, et al. "Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.." Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009. https://doi.org/10.1089/jop.2008.0074

RethinkPeptides

RethinkPeptides Research Database. "Protective effect of intravitreal injection of vasoactive in..." RPEP-01460. Retrieved from https://rethinkpeptides.com/research/camelo-2009-protective-effect-of-intravitreal

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.